Considering that different combined polymorphisms were related to a more increased risk of cancer, the TP53 and XPD genotype combinations were also analyzed in this study for correlations with the increased risk of lung cancer, but these results are not statistically significant. The gene discussed is ERCC2; the disease is lung carcinoma.